Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

VitaNova Life Sciences (YJGJ) Cash from Operations (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Cash from Operations for 9 consecutive years, with 212661.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 2327.64% year-over-year to 212661.0, compared with a TTM value of 1164486.0 through Oct 2025, up 239.13%, and an annual FY2025 reading of 192774.0, up 151.29% over the prior year.
  • Cash from Operations was 212661.0 for Q4 2025 at VitaNova Life Sciences, down from 263810.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 479137.0 in Q2 2025 and bottomed at 504001.0 in Q3 2024.
  • Average Cash from Operations over 5 years is 14070.32, with a median of 2285.0 recorded in 2023.
  • The sharpest move saw Cash from Operations plummeted 8266.96% in 2024, then skyrocketed 2327.64% in 2025.
  • Year by year, Cash from Operations stood at 19593.0 in 2021, then crashed by 72.92% to 5306.0 in 2022, then plummeted by 250.6% to 7991.0 in 2023, then skyrocketed by 209.62% to 8760.0 in 2024, then surged by 2327.64% to 212661.0 in 2025.
  • Business Quant data shows Cash from Operations for YJGJ at 212661.0 in Q4 2025, 263810.0 in Q3 2025, and 479137.0 in Q2 2025.